1. Home
  2. IDYA vs DAN Comparison

IDYA vs DAN Comparison

Compare IDYA & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$32.39

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Dana Incorporated

DAN

Dana Incorporated

HOLD

Current Price

$32.10

Market Cap

3.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
DAN
Founded
2015
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.3B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IDYA
DAN
Price
$32.39
$32.10
Analyst Decision
Strong Buy
Buy
Analyst Count
14
5
Target Price
$49.67
$31.40
AVG Volume (30 Days)
858.2K
1.8M
Earning Date
02-13-2026
02-18-2026
Dividend Yield
N/A
1.26%
EPS Growth
N/A
N/A
EPS
N/A
0.39
Revenue
$214,834,000.00
$9,957,000,000.00
Revenue This Year
$2,688.43
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$81.44
Revenue Growth
5377.66
17.78
52 Week Low
$13.45
$10.11
52 Week High
$39.28
$31.81

Technical Indicators

Market Signals
Indicator
IDYA
DAN
Relative Strength Index (RSI) 41.60 77.03
Support Level $31.54 $29.70
Resistance Level $34.66 $31.01
Average True Range (ATR) 1.38 1.20
MACD -0.32 0.05
Stochastic Oscillator 16.84 93.86

Price Performance

Historical Comparison
IDYA
DAN

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Share on Social Networks: